ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 812 filers reported holding ISHARES TR in Q3 2023. The put-call ratio across all filers is 3.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,813 | -1.5% | 2,329 | +2.3% | 0.03% | -19.4% |
| Q2 2023 | $289,088 | -0.7% | 2,277 | +1.1% | 0.04% | -25.0% |
| Q1 2023 | $290,997 | -11.4% | 2,253 | -10.0% | 0.05% | -20.0% |
| Q4 2022 | $328,619 | +8.1% | 2,503 | -3.8% | 0.06% | -18.9% |
| Q3 2022 | $304,000 | -0.7% | 2,603 | 0.0% | 0.07% | +10.4% |
| Q2 2022 | $306,000 | -27.7% | 2,603 | -19.7% | 0.07% | -23.0% |
| Q1 2022 | $423,000 | +5.2% | 3,243 | +23.2% | 0.09% | +1.2% |
| Q4 2021 | $402,000 | -10.5% | 2,633 | -5.1% | 0.09% | -24.6% |
| Q3 2021 | $449,000 | +35.6% | 2,775 | +37.0% | 0.11% | +26.7% |
| Q2 2021 | $331,000 | +30.3% | 2,025 | +19.8% | 0.09% | -20.4% |
| Q1 2021 | $254,000 | -0.8% | 1,690 | 0.0% | 0.11% | -9.6% |
| Q4 2020 | $256,000 | +10.3% | 1,690 | -1.4% | 0.12% | -3.1% |
| Q3 2020 | $232,000 | -0.9% | 1,714 | 0.0% | 0.13% | +4.0% |
| Q2 2020 | $234,000 | +28.6% | 1,714 | +1.4% | 0.12% | +2.5% |
| Q1 2020 | $182,000 | -11.7% | 1,690 | -1.0% | 0.12% | -4.0% |
| Q4 2019 | $206,000 | – | 1,707 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |